The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Hepatic Artery Infusion Chemotherapy (HAI) for HCC: Prognostic Factors.
 
Jessica Hopkins
No Relationships to Disclose
 
Vickie E Baracos
No Relationships to Disclose
 
David Bigam
No Relationships to Disclose
 
Dean Eurich
No Relationships to Disclose
 
Michael B. Sawyer
Honoraria - Baxter; Bristol-Myers Squibb; Celgene; Fresenius Kabi; LEO Pharma; Novartis; nutricia; pfizer; Sanofi; Shire
Consulting or Advisory Role - Celgene; LEO Pharma; Nutricia; Pfizer
Research Funding - Bayer (Inst); Bristol-Myers Squibb (Inst); Corvus Pharmaceuticals (Inst); Pfizer (Inst)
Patents, Royalties, Other Intellectual Property - My lab discovered that all the competitive tyrosine kinase inhibitors such as sunitinib and gefitinib have additional pharmacological properties. This additional pharmacologic property causes intestinal epithelial cells to active their chloride channels l
Travel, Accommodations, Expenses - Amgen; LEO Pharma; Novartis Canada Pharmaceuticals Inc; Nutricia; pfizer